Quotient Bioresearch's New Radiochemistry Facility Fully Operational

23-Jun-2010 - United Kingdom

Quotient Bioresearch announced that its new, state-of-the-art radiochemistry facility in Cardiff, UK is fully operational and that shipments of radiolabelled products have commenced. All staff have successfully transferred from the former site operated by Amersham Radiolabelling Services to the new facility.

The new facility, located close to Cardiff Bay, represents a significant investment by Quotient and follows the Company's acquisition of Amersham Radiolabelling Services from GE Healthcare in June 2009. The facility has been named "The Old Glassworks", reflecting the origins of the site on which it was built.

The Old Glassworks will produce radiolabelled compounds for its pharmaceutical, biotechnology and agrochemical clients, offering an established bespoke service for the custom synthesis of carbon-14 and tritium labelled compounds. Quotient's capabilities allow it to manufacture custom radiolabelled drugs for use in both pre-clinical and clinical settings.

Other news from the department manufacturing

More news from our other portals

So close that even
molecules turn red...